Related Experiment Video

Updated: Aug 22, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

Diabetic cardiomyopathy: mechanisms, diagnosis and treatment

Sajad A Hayat1, Billal Patel, Rajdeep S Khattar

  • 1Department of Cardiology, Northwick Park Hospital, Watford Road, Harrow HAI 3UJ, UK.

Clinical Science (London, England : 1979)
|September 3, 2004
PubMed

Insights

Diabetic patients face a higher risk of heart failure due to diabetic cardiomyopathy, a distinct condition. More research is urgently needed to understand its causes and develop targeted treatments.

Area of Science:

  • Cardiology
  • Endocrinology
  • Metabolic Diseases

Background:

  • Diabetic patients exhibit an elevated risk of heart failure, irrespective of coronary artery disease severity.
  • This condition is recognized as a distinct entity termed 'diabetic cardiomyopathy'.
  • Metabolic disturbances are implicated in the functional and structural changes observed in the diabetic heart muscle.

Purpose of the Study:

  • To address the limited translational studies explaining the increased risk of cardiomyopathy and heart failure in diabetic individuals.
  • To highlight the lack of diabetes-specific diagnostic methods for cardiac alterations.
  • To emphasize the need for dedicated pathogenetic, diagnostic, and therapeutic research in diabetic cardiomyopathy.

Main Methods:

  • Review of experimental and translational studies on diabetic cardiomyopathy.
  • Analysis of current diagnostic limitations for cardiac dysfunction in diabetes.
  • Evaluation of existing treatment strategies for heart failure in diabetic patients.

Main Results:

  • Experimental data suggest metabolic perturbations are key to diabetic cardiomyopathy.
  • Current diagnostic tools lack specificity for diabetes-related cardiac changes.
  • Treatment approaches are largely extrapolated from non-diabetic heart failure populations.

Conclusions:

  • There is an urgent need for pathogenetic studies to elucidate the mechanisms initiating and progressing diabetic cardiomyopathy.
  • Development of diabetes-specific diagnostic tools is crucial.
  • Targeted therapeutic strategies are required for effective treatment of diabetic cardiomyopathy and heart failure.

More Related Videos

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model05:58

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model

Published on: April 18, 2025

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.